Clinical Trials
152 trialsPembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center
Pembrolizumab in Treating Patients With Malignant Mesothelioma
University of Chicago
INFINITE
Ferring Ventures Limited
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
Roswell Park Cancer Institute
Short Neoadjuvant Hemithoracic IMRT for MPM
University Health Network, Toronto
From Presentation to Diagnosis: Patterns of Pleural Effusion
Mansoura University Hospital
MesoPDT
University Hospital, Lille
CheckMate 6DW
Bristol-Myers Squibb
DREAM3R
PrECOG, LLC.
......SMARTEST Trial......
University Health Network, Toronto
BIMES
Fundación GECP
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
H. Lee Moffitt Cancer Center and Research Institute
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
SPECTAlung
European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
The Cleveland Clinic
Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma
Oncovir, Inc.
NERO
University Hospital Southampton NHS Foundation Trust
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
Memorial Sloan Kettering Cancer Center
MESODEC
University Hospital, Antwerp
CAR T Cells in Mesothelin Expressing Cancers
University of Pennsylvania
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Alliance for Clinical Trials in Oncology
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
8479217
BerGenBio ASA
A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Bristol-Myers Squibb
Dendritic Cell Vaccination for Patients with Solid Tumors
University Hospital, Antwerp
Alvopem® (Pemetrexed) Safety Assessment
NanoAlvand
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
Sellas Life Sciences Group
Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma
Ain Shams University
SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II
Swiss Cancer Institute
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Prelude Therapeutics
eRAPID: Online Symptom Reporting in Lung Cancer
University of Leeds
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
Memorial Sloan Kettering Cancer Center
ATOMIC
Polaris Group
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
PrE0505
PrECOG, LLC.
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Eastern Cooperative Oncology Group
First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin
Bayer
Diadem
Mario Negri Institute for Pharmacological Research
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients
University Health Network, Toronto
NVB Metro
Assistance Publique Hopitaux De Marseille
Dasatinib in Resectable Malignant Pleural Mesothelioma
M.D. Anderson Cancer Center
Amatuximab
Morphotek
Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients
Istituto Clinico Humanitas
Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients
Istituto Clinico Humanitas
A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma
Sumitomo Pharma Co., Ltd.
A Study of LY3023414 in Participants With Advanced Cancer
Eli Lilly and Company
MESOIMMUNE
Centre Hospitalier Intercommunal Creteil
Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
Barbara Ann Karmanos Cancer Institute